{"filing":{"accession_number":"0001711279-26-000047","cik":"0001711279","ticker":"KRYS","company_name":"Krystal Biotech, Inc.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"krys-20260515.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1711279/000171127926000047/krys-20260515.htm"},"events":[{"id":9940,"run_id":8715,"accession_number":"0001711279-26-000047","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure of shareholder vote results from Krystal Biotech's 2026 Annual Meeting held on May 15, 2026. The filing reports final voting tallies on four proposals: election of Class III directors (Krishnan and Mason), ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the Non-Employee Director Compensation Policy. All proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and compensation oversight.","company_name":"Krystal Biotech, Inc.","ticker":"KRYS","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":772,"accession_number":"0001711279-26-000047","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Krystal Biotech's 2026 Annual Meeting held on May 15, 2026. The filing reports final voting tallies on four proposals: election of Class III directors (Krishnan and Mason), ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the Non-Employee Director Compensation Policy. All proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and compensation oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:56:50.474592+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":772,"accession_number":"0001711279-26-000047","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from Krystal Biotech's 2026 Annual Meeting held on May 15, 2026. The filing reports final voting tallies on four proposals: election of Class III directors (Krishnan and Mason), ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the Non-Employee Director Compensation Policy. All proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and compensation oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:56:50.474592+00:00","company_name":"Krystal Biotech, Inc.","ticker":"KRYS","filing_date":"2026-05-20"}]}